Breaking News Instant updates and real-time market news.

APRN

Blue Apron

$1.08

-0.035 (-3.15%)

04:55
11/28/18
11/28
04:55
11/28/18
04:55

Blue Apron management to meet with Oppenheimer

Meeting to be held in New York on November 28 hosted by Oppenheimer.

  • 28

    Nov

APRN Blue Apron
$1.08

-0.035 (-3.15%)

11/15/18
GUGG
11/15/18
DOWNGRADE
GUGG
Neutral
Blue Apron downgraded to Neutral from Buy at Guggenheim
11/15/18
STFL
11/15/18
NO CHANGE
Target $1.5
STFL
Hold
Blue Apron price target lowered to $1.50 from $2.00 at Stifel
Stifel analyst Scott Devitt noted that Blue Apron's Q3 revenue came in below estimates while its adjusted EBITDA beat expectations. The company also guided to revenue and active customers being down year-over-year in FY19, due to plans to rationalize its marketing spend and streamline its product development efforts to focus primarily on its most loyal users. Devitt, who thinks the reduced marketing and product development spending limits visibility into near-term growth potential, lowered his price target on Blue Apron shares to $1.50 from $2.00 and keeps a Hold rating on the stock.
11/15/18
LEHM
11/15/18
NO CHANGE
Target $1.25
LEHM
Equal Weight
Blue Apron price target lowered to $1.25 from $2.50 at Barclays
Barclays analyst Ross Sandler halved his price target for Blue Apron Holdings to $1.25 following the company's Q3 results. The analyst says that while he's encouraged by the progress the company is seeing in transitioning its model, he remains on the sidelines until the key financial metrics improve. He keeps an Equal Weight rating on the shares.
11/15/18
11/15/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Blue Apron (APRN) downgraded to Neutral from Buy at Guggenheim with analyst Michael Graham saying the company's net loss of 71K customers was higher than anticipated even though EBITDA came in higher than expected. 2. Horizon Pharma (HZNP) downgraded to Neutral from Buy at Mizuho with analyst Irina Koffler saying after she spoke with management about planned investments in teprotumumab pre-launch and the Mirror trial, she reduced her 2019 forecasts for Krystexxa and Actimmune to below consensus. 3. Cabot Oil & Gas (COG) downgraded to Hold from Buy at Tudor Pickering. 4. Hawaiian Electric (HE) downgraded to Underperform from Neutral at BofA/Merrill with analyst Julien Dumoulin-Smith citing strong relative share performance on investor activism. 5. PG&E (PCG) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Stephen Byrd saying he sees an "unprecedented" level of uncertainty given that there is currently no liability cap that would be applied to 2018 wildfires. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

RSAIF

RSA Insurance

$0.00

(0.00%)

05:47
12/10/18
12/10
05:47
12/10/18
05:47
Upgrade
RSA Insurance rating change  »

RSA Insurance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWDHF

Skyworth Digital

$0.00

(0.00%)

05:45
12/10/18
12/10
05:45
12/10/18
05:45
Downgrade
Skyworth Digital rating change  »

Skyworth Digital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$40.72

-2.17 (-5.06%)

05:44
12/10/18
12/10
05:44
12/10/18
05:44
Hot Stocks
Biohaven announces initial 'positive' results from ongoing rimegepant study »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$73.87

0.1 (0.14%)

, GSK

GlaxoSmithKline

$37.28

-0.125 (-0.33%)

05:42
12/10/18
12/10
05:42
12/10/18
05:42
Downgrade
Tesaro, GlaxoSmithKline rating change  »

Tesaro downgraded to…

TSRO

Tesaro

$73.87

0.1 (0.14%)

GSK

GlaxoSmithKline

$37.28

-0.125 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWARF

Norwegian Air Shuttle

$0.00

(0.00%)

05:40
12/10/18
12/10
05:40
12/10/18
05:40
Upgrade
Norwegian Air Shuttle rating change  »

Norwegian Air Shuttle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASX

ASE Technology

$3.77

-0.06 (-1.57%)

05:39
12/10/18
12/10
05:39
12/10/18
05:39
Earnings
ASE Technology reports November revenue down 3.2% to $1.23B »

Reports November IC-atm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$18.42

0.41 (2.28%)

05:38
12/10/18
12/10
05:38
12/10/18
05:38
Periodicals
Rice Energy brothers want to take over running EQT, WSJ reports »

Derek and Toby Rice, who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ALNY

Alnylam

$74.28

-5.45 (-6.84%)

05:37
12/10/18
12/10
05:37
12/10/18
05:37
Hot Stocks
Alnylam announces settlement with Silence Therapeutics »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$53.08

-0.16 (-0.30%)

05:36
12/10/18
12/10
05:36
12/10/18
05:36
Hot Stocks
Bristol-Myers enters new clinical collaboration with Vedanta Biosciences »

Bristol-Myers and Vedanta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Dec

  • 24

    Jan

  • 20

    May

QDEL

Quidel

$48.48

-12.835 (-20.93%)

05:35
12/10/18
12/10
05:35
12/10/18
05:35
Conference/Events
Quidel to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

IQ

iQIYI

$18.51

-1.34 (-6.75%)

, CHL

China Mobile

$49.28

0.61 (1.25%)

05:34
12/10/18
12/10
05:34
12/10/18
05:34
Hot Stocks
iQIYI signs partnership with China Mobile »

iQIYI (IQ) recently…

IQ

iQIYI

$18.51

-1.34 (-6.75%)

CHL

China Mobile

$49.28

0.61 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QDEL

Quidel

$48.48

-12.835 (-20.93%)

05:27
12/10/18
12/10
05:27
12/10/18
05:27
Recommendations
Quidel analyst commentary  »

Quidel shares likely flat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:24
12/10/18
12/10
05:24
12/10/18
05:24
Hot Stocks
Roche CEO Daniel O'Day to step down, Genentech CEO William Anderson to succeed »

Roche (RHHBY) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 24

    Dec

  • 18

    Mar

EA

Electronic Arts

$82.57

-1.29 (-1.54%)

05:22
12/10/18
12/10
05:22
12/10/18
05:22
Recommendations
Electronic Arts analyst commentary  »

Electronic Arts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$68.17

-2.01 (-2.86%)

, RHHBY

Roche

$0.00

(0.00%)

05:21
12/10/18
12/10
05:21
12/10/18
05:21
Hot Stocks
Gilead appoints Roche CEO Daniel O'Day as CEO, chairman »

Gilead Sciences announced…

GILD

Gilead

$68.17

-2.01 (-2.86%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 24

    Dec

  • 18

    Mar

FIVE

Five Below

$95.53

-6.19 (-6.09%)

05:16
12/10/18
12/10
05:16
12/10/18
05:16
Upgrade
Five Below rating change  »

Five Below upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMXAY

Genmab

$0.00

(0.00%)

05:12
12/10/18
12/10
05:12
12/10/18
05:12
Upgrade
Genmab rating change  »

Genmab upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCBJY

UCB

$0.00

(0.00%)

05:10
12/10/18
12/10
05:10
12/10/18
05:10
Upgrade
UCB rating change  »

UCB upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWTUY

Swedish Orphan Biovitrum

$0.00

(0.00%)

05:08
12/10/18
12/10
05:08
12/10/18
05:08
Upgrade
Swedish Orphan Biovitrum rating change  »

Swedish Orphan Biovitrum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$27.63

-0.105 (-0.38%)

, JNJ

Johnson & Johnson

$145.38

-0.52 (-0.36%)

05:06
12/10/18
12/10
05:06
12/10/18
05:06
Upgrade
MorphoSys, Johnson & Johnson rating change  »

MorphoSys upgraded to Buy…

MOR

MorphoSys

$27.63

-0.105 (-0.38%)

JNJ

Johnson & Johnson

$145.38

-0.52 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

SLG

SL Green Realty

$93.32

-2.41 (-2.52%)

05:02
12/10/18
12/10
05:02
12/10/18
05:02
Upgrade
SL Green Realty rating change  »

SL Green Realty upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMA

Comerica

$74.07

-1.04 (-1.38%)

04:59
12/10/18
12/10
04:59
12/10/18
04:59
Downgrade
Comerica rating change  »

Comerica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

PII

Polaris Industries

$88.44

-2.37 (-2.61%)

04:58
12/10/18
12/10
04:58
12/10/18
04:58
Downgrade
Polaris Industries rating change  »

Polaris Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MPX

Marine Products

$21.59

-0.21 (-0.96%)

04:56
12/10/18
12/10
04:56
12/10/18
04:56
Downgrade
Marine Products rating change  »

Marine Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VC

Visteon

$67.58

-4.1 (-5.72%)

04:55
12/10/18
12/10
04:55
12/10/18
04:55
Downgrade
Visteon rating change  »

Visteon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.